Epoetin alfa every four weeks vs with every two weeks
Adverse events: hypertension · anaemia in predialysis patients
Epoetin alfa every four weeks showed no clear difference in adverse events: hypertension compared with with every two weeks (moderate certainty).
1 finding from 1 review
- Short‐acting erythropoiesis‐stimulating agents for anaemia in predialysis patients 2017 · Cochrane Headline outcomes onlyRR 1.02 [0.62, 1.69]3 studies · 724 participantsModerate